Sulforaphane for Autism
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if sulforaphane, a compound from vegetables like broccoli, can improve core symptoms in people with autism. Participants will receive either sulforaphane or a placebo (a dummy treatment) to compare results. The study will also examine how different individuals might respond based on their body chemistry and genetics. It seeks males aged 13-30 with a diagnosed autistic disorder who haven't experienced seizures in the last two years and do not have significant kidney, liver, or thyroid issues. As a Phase 2 trial, this research focuses on measuring the treatment's effectiveness in an initial, smaller group of people.
Do I need to stop my current medications for the trial?
The trial information does not specify if you need to stop taking your current medications. However, if you have a current infection or are being treated with antibiotics, you may not be eligible to participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that sulforaphane, a substance in broccoli, is generally safe for people. Studies have found that products high in sulforaphane can be used safely for up to six months. Trials with people who have autism found that sulforaphane was mostly well-tolerated. However, some mild side effects, like stomach upset, have been reported. One study noted that two people with a history of seizures experienced seizures again, highlighting the need for careful monitoring in such cases. Overall, evidence suggests that sulforaphane is safe for most people, but individual reactions can differ.12345
Why do researchers think this study treatment might be promising for autism?
Unlike standard autism treatments that often focus on behavioral therapy or medications like antipsychotics and stimulants, sulforaphane is unique because it's derived from broccoli seeds and offers a nutritional approach. Researchers are excited about sulforaphane because it works by potentially targeting oxidative stress and inflammation in the brain, which are not directly addressed by current medications. Additionally, sulforaphane's natural origin and its novel mechanism make it a promising alternative or complement to existing therapies, with the potential for fewer side effects.
What evidence suggests that sulforaphane might be an effective treatment for autism?
Research has shown that sulforaphane, a natural compound in broccoli, might help improve symptoms of autism spectrum disorder (ASD). Studies have found that sulforaphane can lead to positive changes in behavior and communication for people with ASD. In this trial, some participants will receive sulforaphane. Previous controlled trials discovered that participants taking sulforaphane had better social interaction and verbal communication than those taking a placebo. Another study suggested that sulforaphane might boost brain chemicals that protect against stress and inflammation. Overall, current evidence suggests that sulforaphane is a promising and safe option for treating ASD symptoms.12678
Who Is on the Research Team?
Steven Buyske
Principal Investigator
Rutgers, The State University of NJ
Are You a Good Fit for This Trial?
This trial is for males aged 13-30 with a diagnosis of autistic disorder in New Jersey. Participants must have a parent or guardian's consent and be able to complete all study visits. They should not have kidney, liver, thyroid issues, current infections, recent major surgery or chronic diseases like heart disease or diabetes.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Baseline assessments are conducted before treatment begins
Treatment
Participants receive either sulforaphane or placebo for 18 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Placebo
- Sulforaphane
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rutgers, The State University of New Jersey
Lead Sponsor
Rowan University
Collaborator